Ledger.Open graph →
SEC Form D · Amendment · filed October 11, 2022

Phoenicis Therapeutics, Inc

Offering
$10.0M
Sold
$9.9M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
HINGHAM, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Joff Masukawa · Hingham, MADirectorAlexander Silver · HIngham, MADirectorHal Landy · Hingham, MADirectorMark P. De Souza · Hingham, MADirectorDeborah Ramsdell · Hingham, MAExec · DirectorRick C. Hurd · CHICAGO, ILDirectorErin H. Ankin · CHICAGO, ILDirectorAnthony Divalerio, Iii · Malvern, PADirectorJeffrey N. Pentland · Toronto, Ontario, CanadaDirectorMomin Sheikh · Malvern, PAExec · DirectorCurt Cronin · New York, NYDirectorJohn Joseph · New York, NYDirectorHunter Arnold · New York, NYExec · DirectorSpencer Mckenney · SEATTLE, WADirectorJenna Woods · San Diego, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗